Standard Operating Procedure for Conducting Stability Studies Under US FDA CFR Title 21

1) Purpose

The purpose of this SOP is to provide a standardized approach for conducting stability studies for drug products in compliance with US FDA CFR Title 21, ensuring that they meet the required quality standards over their shelf life.

2) Scope

This SOP applies to all drug products for which stability studies are conducted under US FDA regulations. It is relevant to departments involved in production, quality control, quality assurance, and regulatory compliance.

3) Responsibilities

• Quality Control (QC) Team: Conducts stability testing according to the protocol and FDA guidelines.
• Quality Assurance (QA) Team: Reviews and approves stability protocols and reports.
• Regulatory Affairs Team: Ensures compliance with US FDA requirements for stability testing.

4) Procedure

1. Preparation of Stability Protocol
   1. Draft a protocol detailing storage conditions, test intervals, and analytical methods
      

      “The Assurance of Safe and Effective Medications: Cutting-edge Methods for Pharmaceutical Stability Testing Unveiled”

      per US FDA CFR Title 21.
   2. Submit the protocol for review and approval to the QA team.
2. Execution of Stability Study
   1. Store samples in designated stability chambers under specified conditions (e.g., 25°C/60% RH, 40°C/75% RH).
   2. Conduct analytical tests at each specified interval to assess stability parameters.
   3. Record all observations, test results, and any deviations from the